Azitra's Convertible Note Round

Azitra raised a round of funding on May 02, 2018.

Azitra is developing a recombinant strain of skin-safe bacterium that secrete therapeutic proteins. These proteins are missing from the skin's microbiome when a person suffers from problems like eczem…

Articles about Azitra's Convertible Note Round: